-+ 0.00%
-+ 0.00%
-+ 0.00%

Cellebrite raises FY26 adjusted EBITDA forecast to $163 million-$166 million

PUBT·11/12/2026 13:16:11
Cellebrite raises FY26 adjusted EBITDA forecast to $163 million-$166 million
  • Cellebrite’s Nov. 12, 2026, outlook raised fiscal 2026 adjusted EBITDA guidance to $163 million-$166 million.
  • Full-year revenue guidance was narrowed to $553 million-$558 million, implying growth of 16%-17%.
  • Annual recurring revenue guidance remained $550 million-$560 million, representing growth of 14%-16%.
  • Fourth-quarter expectations call for revenue of $145 million-$150 million, with adjusted EBITDA of $47 million-$50 million.
  • Third-quarter revenue rose 18% to $149 million; adjusted EBITDA increased 42% to $54 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellebrite DI Ltd. published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.